Natamycin

Identity and antimicrobial spectrum

Natamycin, also called pimaricin and identified in the European system as E 235, is a polyene antifungal compound produced by Streptomyces fermentation. It binds fungal membrane sterols and is active against many yeasts and moulds. It is not a broad bacterial control and must not be credited against Salmonella, Listeria, Clostridium botulinum or other meat pathogens without separate evidence. In cured meats its technological role is usually surface protection, where oxygen and moisture can support fungal growth during drying or storage. This differs from a starter mould deliberately applied for ripening. The control question is whether natamycin suppresses unwanted surface fungi while the intended process ecology and legal product identity are preserved. Its presence does not sterilise a casing, remove preformed mycotoxin or correct an unsanitary chamber.

Legal scope and product identity

Authorisation is jurisdiction-, additive-, food-category- and use-specific. European additive law permits natamycin only for defined foods and conditions, including specified surface uses; the current consolidated regulation and later amendments must be checked for the exact dried cured product. Codex provisions and national rules may classify foods differently. A safety opinion is not itself permission, and permission for cheese cannot be transferred to salami. The operator should record the product category, maximum level or surface condition, application route, residue or penetration condition where applicable, and labelling duty. A supplier's food-grade certificate establishes material quality, not lawful use in every market. Export production may require different recipes or may prohibit the proposed treatment. Traditional or protected-product specifications can impose a separate restriction even when horizontal additive law allows a use.

Application and operating control

Surface treatment may be applied by dipping, spraying or a controlled coating system where lawful. Performance depends on working concentration, coverage, contact, surface moisture, casing, product geometry, fungal load and subsequent chamber conditions. The concentrate, working bath and deposited residue are different measurements. Baths can become diluted or contaminated; spray nozzles can block; racks can shadow surfaces; and rough natural casings can receive uneven coverage. Operators need controlled preparation, suitable water, agitation where required, replacement criteria, identified utensils and records linking treatment to the lot. More natamycin is not automatically more effective or lawful. Internal addition should never be inferred from a surface permission. Verification can combine solution checks, coverage assessment, residue testing where required and fungal trends, but each method has a defined scope.

Interaction with ripening ecology

A surface antifungal can also suppress desirable ripening yeasts or moulds. Product design should decide whether the surface is intended to remain clean, support a selected culture or develop a traditional mixed flora. Applying natamycin after desirable inoculation can defeat that design, while applying it to an already established unwanted mould may stop further growth without removing biomass or toxin. Surface humidity, condensation, air exchange, rack sanitation and spore pressure remain primary controls. A recurring need for heavy treatment may indicate a chamber or zoning problem. The producer should assess flavour, appearance, drying and casing peel as well as fungal counts. Natamycin is a hurdle within a system, not a substitute for environmental control or a licence to extend maturation under wet, contaminated conditions.

Deviation and evidence limits

Wrong concentration, an unapproved product, incomplete coverage, treatment after visible toxicogenic growth or missing records requires containment. Restoring the bath does not decide the status of product treated earlier. Visible cleaning cannot prove that mycotoxin is absent, and a negative surface swab does not establish lawful residue or penetration. The lot assessment uses actual formulation, application, fungal identity where relevant, toxin evidence, market law and protected specification. Re-treatment is acceptable only when permitted and supported for cumulative exposure and quality. Root-cause action may address solution preparation, nozzles, casing, chamber condensation, sanitation, culture design or supplier instructions. Release remains separate from correction and should not rely on the fact that the surface looks clean after treatment.